Lurking deep inside some tumors are “factories” full of immune cells that help the body fight a rearguard action against cancer and are key to helping some patients recover, new research shows.
In recent years doctors have turned to a new treatment for cancer, immunotherapy, which works by leveraging the body’s own immune system to fight tumors.
The technique has largely focused on white blood cells called T-cells, which are “trained” to recognize and attack cancer cells.
But the innovative treatment only works well for around 20 percent of patients, and researchers have been trying to understand why some people respond better than others.
Three papers published on Thursday in the journal Nature point the way, identifying a key formation inside some tumors: tertiary lymphoid structures (TLS).
These structures function like “factories or schools” for immune cells that help the body fight cancer, said Wolf Fridman, Professor Emeritus of Immunology of Universite de Paris at the Centre de Recherche des Cordeliers, who helped lead one of the studies.
“The cells need to be educated in schools, which are the tertiary lymphoid structures,” where they effectively learn to recognise and attack cancer cells, Fridman told AFP.
– No longer ‘innocent bystanders’ –
Key to the findings is that T-cells are far from the only immune cells capable of taking the fight to cancer, with researchers finding the TLS were full of B-cells, a kind of immune cell that produces antibodies.
“We have been T-cell addicts for 15 years in cancer,” Fridman said with a laugh.
“We analyzed these sarcomas to see what groups they had and what’s striking is that these B-cells appeared.”
Beth Helmink, a fellow in surgical oncology at the University of Texas’s MD Anderson Cancer Center who worked on a second study, said the research changed perceptions of the role of B-cells in immunotherapy.
“Through these studies, we find that B-cells are not just innocent bystanders, but are themselves contributing in a meaningful way to the anti-tumor immune response,” she said in a statement issued by the Center.
The discovery is something of a surprise, as an abundance of B-cells in cancer patients has sometimes been seen as a marker for poor prognosis.
But the studies found that patients with high levels of B-cells inside TLS in their tumors were more likely to respond well to immunotherapy.
“These three studies provide exciting data demonstrating that… B cells which make antibodies significantly influence the responsiveness of patients with certain cancers to immunotherapy,” said Lawrence Young, director of the University of Warwick’s Cancer Research Center, who was not involved in the studies.
The work “could be used to improve the effectiveness of cancer immunotherapy for all patients”, he said.
– Improving cancer treatment –
There are still many unanswered questions.
Scientists are not yet sure why the structures form in some tumors and not others.
And while it now seems clear that B-cells inside the structures play a key role in the success of immunotherapy, scientists aren’t sure precisely how.
It may be that the B-cells are on the frontlines, producing antibodies that attack cancer cells efficiently.
Or they may be bolstering T-cells, or perhaps doing both.
And not all TLS are created equal: the researchers found three categories, but only one type was “mature” enough to churn out cancer-fighting immune cells.
Going forward, the research opens several promising avenues, the authors said.
Initially, it could help doctors screen patients to see which are most likely to respond well to immunotherapy.
And eventually, the research could mean more patients could be successfully treated with the technique, said Goran Jonsson, a professor of oncology and pathology at Lund University who worked on a third study.
“If we come up with a treatment that could enhance TLS formation, we could combine this with current immunotherapy regimens,” he told AFP.
“Most likely this would lead to more patients responding to immunotherapy.”
Trump spent 45 minutes talking with cast of right-wing play dramatizing ‘Deep State’ conspiracy theories: report
The coronavirus emergency has given President Donald Trump one of the most daunting tests of his administration, with less than a year to go before he stands for re-election.
And yet in the midst of all the chaos, one thing the president found time to do on Thursday was meet with the cast of a bizarre right-wing play dramatizing the supposed "deep state" plot at the FBI to frame Trump in the Russia investigation.
According to The Daily Beast, Trump spent 45 minutes talking with the people behind "FBI Lovebirds: Undercovers," which focuses on the affair between FBI officials Peter Strzok and Lisa Page. The leading roles of Strzok and Page were played by Dean Cain, the former Superman actor, and Kristy Swanson, who played the starring role in the 1992 Buffy the Vampire Slayer movie.
‘This is a nightmare’: Trump accused of weaponizing DOJ with new task force focused on stripping US citizenship
"Of all the dystopian sh*t—a department of denaturalization at DOJ might take the biscuit."
Rights advocates expressed outrage and severe concerns after the U.S. Department of Justice announced Wednesday it is creating an official task force devoted to "denaturalization"—the process by which the government strips citizenship from foreign-born Americans, or naturalized citizens.
"Of all the dystopian shit—a department of denaturalization at DOJ might take the biscuit," tweeted activist Joel Braunold. "Means immigrant Americans (such as myself) will always have a threat to displace us if we step out of line."
All US Navy ships in the Pacific near countries with coronavirus ordered to self-quarantine for 14 days
CNN National Security reporter Ryan Browne tweeted Thursday that the U.S. Navy has ordered all of its vessels in the Pacific that have been near countries with COVID-19, also known as the coronavirus, "to remain at sea for at least 14 days before pulling into another port in order to monitor sailors for any symptoms of the virus."
Health experts have said that the two-week period should give enough time for infected people to become aware that they are sick.
The highly-contagious disease has spread very quickly in South Korea and California after public exposure. The first person verified with "community-spread" transmission was identified just outside of Sacramento, California.